Publication Name	World Journal of Psychiatry
Manuscript ID	27936
Country	Canada

Received	2016-06-22 08:29
Peer-Review Started	2016-06-27 16:52
First Decision by Editorial Office Director
Return for Revision	2016-08-11 16:01
Revised	2016-08-19 00:55
Publication Fee Transferred
Second Decision by Editor	2016-10-14 14:25
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2016-10-27 17:39
Articles in Press	2016-10-27 17:39
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-12-13 12:16
Publish the Manuscript Online	2016-12-20 19:15

ISSN	2220-3206 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Psychiatry
Manuscript Type	Review
Article Title	Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology
Manuscript Source	Invited Manuscript
All Author List	Sean A Rasmussen, Michael F Mazurek and Patricia I Rosebush
Funding Agency and Grant Number
Corresponding Author	Sean A Rasmussen, PhD, MINDS Program, McMaster University, 1280 Main Street West, Hamilton L8S 4K1, Ontario, Canada. sa.rasmuss@gmail.com
Key Words	Catatonia; Schizophrenia; Benzodiazepines; Electroconvulsive therapy; Extrapyramidal disorders
Core Tip	Catatonia is a complex clinical syndrome occurring in more than 10% of patients with acute psychiatric illnesses, and it is associated with multiple life-threatening complications. In the last several decades, renewed interest in this syndrome has led to a great deal of research and debate regarding its diagnosis and treatment. In this paper, we present a review of the current literature on catatonia along with findings from the 220 cases we have assessed and treated since 1989. Catatonia itself is readily treated using low-dose lorazepam, and it also has important implications for how other underlying psychiatric con-ditions should be treated.
Publish Date	2016-12-20 19:15
Citation	Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatr 2016; 6(4): 391-398
URL	http://www.wjgnet.com/2220-3206/full/v6/i4/391.htm
DOI	http://dx.doi.org/10.5498/wjp.v6.i4.391

Full Article (PDF)	WJP-6-391.pdf
Full Article (Word)	WJP-6-391.doc
Manuscript File	27936-Review.docx
Answering Reviewers	27936-Answering reviewers.pdf
Audio Core Tip	27936-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	27936-Conflict-of-interest statement.pdf
Copyright License Agreement	27936-Copyright assignment.pdf
Peer-review Report	27936-Peer-review(s).pdf
Scientific Misconduct Check	27936-Scientific misconduct check.pdf
Scientific Editor Work List	27936-Scientific editor work list.pdf